Outwitting evolution: fighting drug-resistant TB, malaria, and HIV

Cell. 2012 Mar 16;148(6):1271-83. doi: 10.1016/j.cell.2012.02.021.

Abstract

Although caused by vastly different pathogens, the world's three most serious infectious diseases, tuberculosis, malaria, and HIV-1 infection, share the common problem of drug resistance. The pace of drug development has been very slow for tuberculosis and malaria and rapid for HIV-1. But for each disease, resistance to most drugs has appeared quickly after the introduction of the drug. Learning how to manage and prevent resistance is a major medical challenge that requires an understanding of the evolutionary dynamics of each pathogen. This Review summarizes the similarities and differences in the evolution of drug resistance for these three pathogens.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drug Resistance*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • Humans
  • Malaria / drug therapy*
  • Malaria / parasitology
  • Mycobacterium tuberculosis / drug effects
  • Plasmodium / drug effects
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology